Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-02-01 @ 4:27 PM
Study NCT ID:
NCT07194850
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2025-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Sponsor:
argenx
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Immune Thrombocytopenia (ITP) | View |
| None | ITP - Immune Thrombocytopenia | View |
| None | ITP | View |
| None | Immune Thrombocytopenic Purpura | View |
| None | Immune Thrombocytopenic Purpura ( ITP ) | View |
| None | Idiopathic Thrombocytopenic Purpura | View |
| None | Idiopathic Thrombocytopenic Purpura (ITP) | View |
Keywords: